BriaCell Therapeutics (BCTX) Institutional Ownership $0.60 +0.03 (+5.24%) (As of 11/20/2024 ET) Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Institutional Ownership Changes (13F Filings) for BriaCell Therapeutics (NASDAQ:BCTX)CurrentInstitutional OwnershipPercentage15.42%Number ofInstitutional Buyers(last 12 months)4TotalInstitutional Inflows(last 12 months)$464.81KNumber ofInstitutional Sellers(last 12 months)2TotalInstitutional Outflows(last 12 months)$1.47M Get BCTX Insider Trade Alerts Want to know when executives and insiders are buying or selling BriaCell Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data BCTX Institutional Buying and Selling by Quarter Ad Weiss RatingsTrump won. Buy this coin now.Juan Villaverde called the top and bottom of every crypto bull market since 2012. He believes Bitcoin will go to $150,000 — or more. But there’s one coin he thinks could go even higher.This could be his favorite coin. BriaCell Therapeutics Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails10/16/2024 Vontobel Holding Ltd.80,000$99K0.0%N/A0.438% 4/29/2024Onyx Bridge Wealth Group LLC50,000$143K0.0%+66.7%0.313% 4/27/2024 K.J. Harrison & Partners Inc87,044$249K0.0%+7.8%0.545% 2/14/2024 Wasatch Advisors LP267,410$1.56M0.0%-48.0%1.673% 2/12/2024 Redmond Asset Management LLC133,569$781K0.3%-3.1%0.836% 2/6/2024 National Bank of Canada FI7,500$40K0.0%+200.0%0.047% Get the Latest News and Ratings for BCTX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for BriaCell Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 2/2/2024 K.J. Harrison & Partners Inc80,715$476K0.1%+22.1%0.505% 1/31/2024Onyx Bridge Wealth Group LLC30,000$176K0.0%N/A0.188% 11/13/2023 K2 Principal Fund L.P.24,969$156K0.0%N/A0.156% 10/31/2023 K.J. Harrison & Partners Inc66,090$411K0.1%+90.8%0.414% 10/25/2023 Concord Wealth Partners10,775$67K0.0%-29.5%0.067% 8/11/2023 Natixis90,250$579K0.0%N/A0.565% 8/8/2023 Wasatch Advisors LP612,088$3.93M0.0%-0.6%3.830% 8/8/2023 Concord Wealth Partners15,275$98K0.0%-14.1%0.096% 8/2/2023 Bank of Montreal Can34,629$217K0.0%N/A0.217% 7/21/2023 K.J. Harrison & Partners Inc34,640$217K0.0%-67.3%0.217% 4/25/2023 K.J. Harrison & Partners Inc105,933$785K0.2%-75.2%0.683% 2/7/2023Lynwood Capital Management Inc.1,530,000$6.69M8.0%+27.7%9.860% 1/25/2023 K.J. Harrison & Partners Inc427,583$2.52B0.5%-10.9%2.755% 11/8/2022 Apollon Wealth Management LLC17,900$101K0.0%+12.6%0.115% 11/7/2022Virtu Financial LLC48,347$272K0.0%+362.5%0.312% 10/25/2022Lynwood Capital Management Inc.1,198,000$6.73M7.4%+94.8%7.720% 10/21/2022 K.J. Harrison & Partners Inc479,838$2.75M1.0%-70.1%3.092% 8/11/2022 Apollon Wealth Management LLC15,900$92K0.0%+14.4%0.102% 8/2/2022Lynwood Capital Management Inc.615,000$3.55M4.0%-18.0%3.963% 7/27/2022 K.J. Harrison & Partners Inc1,607,027$9.19M2.5%+18.9%10.355% 5/5/2022Lynwood Capital Management Inc.750,000$7.61M8.2%-4.5%4.908% 4/21/2022 K.J. Harrison & Partners Inc1,351,782$13.75M2.2%N/A8.847% 4/20/2022 Concord Wealth Partners16,775$170K0.0%+31.3%0.110% 2/9/2022 Insight Advisors LLC PA16,900$140K0.0%N/A0.106% 2/3/2022 Total Clarity Wealth Management Inc.15,818$131K0.1%+38.5%0.099% 1/21/2022 Concord Wealth Partners12,775$106K0.0%N/A0.080% 11/16/2021 Two Sigma Investments LP62,139$503K0.0%N/A0.404% 11/16/2021 Voloridge Investment Management LLC156,946$1.27M0.0%N/A1.021% 10/22/2021 Redmond Asset Management LLC136,593$1.11M0.3%+3.7%0.890% 10/21/2021 Total Clarity Wealth Management Inc.11,425$93K0.0%N/A0.074% 10/19/2021 Belvedere Trading LLC13,608$107K0.0%N/A0.089% 10/13/2021FNY Investment Advisers LLC4,687$37K0.0%N/A0.031% 10/13/2021Gofen & Glossberg LLC IL10,000$81K0.0%N/A0.065% 8/25/2021 Marshall Wace LLP63,226$337K0.0%N/A0.414% I was wrong. Dead wrong. (Ad)I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we are, a quarter of a century later, almost to the exact day, and it’s happening again. Here’s the full story for you.8/17/2021 Armistice Capital LLC570,343$3.04M0.1%N/A3.735% 8/16/2021 Sabby Management LLC196,033$1.05M0.1%+22.4%1.284% 8/16/2021 Marshall Wace LLP63,226$337K0.0%N/A0.414% 8/13/2021 Altium Capital Management LP800,295$4.27M1.0%N/A5.241% 8/13/2021 Murchinson Ltd.250,000$1.33M0.5%N/A1.637% 8/12/2021 MMCAP International Inc. SPC400,000$2.13M0.1%N/A2.620% 8/12/2021 Kepos Capital LP500,000$2.67M0.2%N/A3.274% 8/12/2021 Eqis Capital Management Inc.21,182$113K0.0%+29.6%0.139% 8/11/2021CVI Holdings LLC320,800$1.71M0.1%N/A2.101% 5/19/2021Virtu Financial LLC15,121$58K0.0%N/A0.260% 5/14/2021 Eqis Capital Management Inc.16,339$63K0.0%N/A0.281% 5/6/2021 Redmond Asset Management LLC131,731$508K0.2%N/A2.266% (Data available from 1/1/2016 forward) BCTX Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of BCTX shares? During the previous two years, 11 institutional investors and hedge funds held shares of BriaCell Therapeutics. The most heavily invested institutionals were Lynwood Capital Management Inc. ($6.69M), Wasatch Advisors LP ($1.56M), Redmond Asset Management LLC ($781K), Natixis ($579K), K.J. Harrison & Partners Inc ($249K), Bank of Montreal Can ($217K), and K2 Principal Fund L.P. ($156K).Learn more on BCTX's institutional investors. What percentage of BriaCell Therapeutics stock is owned by institutional investors? 15.42% of BriaCell Therapeutics stock is owned by institutional investors. Learn more on BCTX's institutional investor holdings. Which institutional investors have been buying BriaCell Therapeutics stock? The following institutional investors have purchased BriaCell Therapeutics stock in the last 24 months: Lynwood Capital Management Inc. ($332K), Natixis ($90.25K), Vontobel Holding Ltd. ($80K), K.J. Harrison & Partners Inc ($52.40K), Onyx Bridge Wealth Group LLC ($50K), Bank of Montreal Can ($34.63K), and K2 Principal Fund L.P. ($24.97K). How much institutional buying is happening at BriaCell Therapeutics? Institutional investors have bought a total of 669,252 shares in the last 24 months. This purchase volume represents approximately $3.07M in transactions. Which BriaCell Therapeutics major shareholders have been selling company stock? The following institutional investors have sold BriaCell Therapeutics stock in the last 24 months: K.J. Harrison & Partners Inc ($445.20K), Wasatch Advisors LP ($250.34K), Concord Wealth Partners ($7K), and Redmond Asset Management LLC ($4.27K). How much institutional selling is happening at BriaCell Therapeutics? Institutional investors have sold a total of 706,809 shares in the last 24 months. This volume of shares sold represents approximately $4.62M in transactions. Related Companies GNLX Major Shareholders ACET Major Shareholders ME Major Shareholders ALLK Major Shareholders CASI Major Shareholders FBLG Major Shareholders PMVP Major Shareholders ONCY Major Shareholders RMTI Major Shareholders CLSD Major Shareholders This page (NASDAQ:BCTX) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredCrypto’s next big bull run?Juan Villaverde may be America’s top crypto expert. And he says something big is coming for crypto – on Nov...Weiss Ratings | Sponsored“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as ...Colonial Metals | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding BriaCell Therapeutics Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share BriaCell Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
